Name | Title | Contact Details |
---|---|---|
Jason Parker Brown |
Chief Financial Officer | Profile |
Jason Brown |
Chief Financial Officer | Profile |
Jonathan Rosin |
Chief Human Resources Officer | Profile |
Makindus is a privately-held, specialty pharmaceutical development company focused on ophthalmology and rare diseases. The Company`s lead product candidate is MI-100, a novel ophthalmic formulation of a legacy compound being developed for Stargardt disease, a rare form of juvenile macular degeneration that occurs in approximately 1 in 10,000 individuals. Makindus has met with the FDA and EMA, and is in the final stages of planning a Phase 3 clinical trial program. The Company is seeking partners and additional sources of funding and collaboration for the development program of MI-100 for Stargardt disease.
At Nerium International, making people better means establishing a business that can bring real change to your life, your skin, and your personal development. Through our partnership with Nerium SkinCare, a division of Nerium Biotechnology, Inc., Nerium International markets breakthrough products validated by real science. These age-defying skincare products are distributed exclusively by our Independent Brand Partners.
STL now operates the world's largest independent dynamic testing facility for tires, wheels and related automotive components, providing the rubber and automotive industries with dynamic laboratory testing, static and physical testing, fleet testing,
Trellis Bioscience is a leader in identifying rare protective antibodies by screening human blood cells.
Metrohm USA Inc is a Riverview, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.